148 filings
Page 3 of 8
6-K
GRCL
Gracell Biotechnologies Inc
14 Aug 23
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:52pm
SC 13D/A
GRCL
Gracell Biotechnologies Inc
11 Aug 23
Gracell Biotechnologies / ORBIMED ADVISORS ownership change
4:23pm
6-K
GRCL
Gracell Biotechnologies Inc
7 Aug 23
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
8:07am
6-K
GRCL
Gracell Biotechnologies Inc
14 Jul 23
Current report (foreign)
6:02am
144
William Cao Wei
20 Jun 23
Notice of proposed sale of securities
4:00pm
144
William Cao Wei
16 Jun 23
Notice of proposed sale of securities
5:03pm
144
Orbimed Capital LLC
15 Jun 23
Notice of proposed sale of securities
4:45pm
144
GRCL
Gracell Biotechnologies Inc
15 Jun 23
Notice of proposed sale of securities
4:39pm
144
Orbimed Advisors LLC
15 Jun 23
Notice of proposed sale of securities
4:32pm
6-K
GRCL
Gracell Biotechnologies Inc
14 Jun 23
Current report (foreign)
6:04am
6-K
GRCL
Gracell Biotechnologies Inc
5 Jun 23
Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting
6:14am
6-K
GRCL
Gracell Biotechnologies Inc
5 Jun 23
Current report (foreign)
6:05am
6-K
GRCL
Gracell Biotechnologies Inc
16 May 23
Gracell announces start of investigator-initiated trial to expand clinical evaluation of FasTCAR-T GC012F into autoimmune disease
4:00pm
6-K
GRCL
Gracell Biotechnologies Inc
16 May 23
Gracell Biotechnologies Reports First Quarter 2023 Unaudited Financial Results, and Provides Corporate Update
6:08am
144
William Cao Wei
13 Apr 23
Notice of proposed sale of securities
11:47am
SC 13D
GRCL
Gracell Biotechnologies Inc
31 Mar 23
Gracell Biotechnologies / ORBIMED ADVISORS ownership change
4:48pm
6-K
GRCL
Gracell Biotechnologies Inc
16 Mar 23
Current report (foreign)
6:10am
6-K
GRCL
Gracell Biotechnologies Inc
15 Mar 23
Current report (foreign)
4:00pm
6-K
GRCL
Gracell Biotechnologies Inc
14 Mar 23
Gracell Biotechnologies Reports Fourth Quarter and Full Year 2022 Unaudited Financial Results, and Provides Corporate Update
6:04am